CDT Equity Inc. Share Price & Technical Analysis
CDT · $0.88 (-15.38%)
Healthcare / Biotechnology
$0.88
-15.38%
CDT Equity Inc., a clinical-stage specialty biopharmaceutical company, develops pharmaceutical products that provides unmet medical needs in the areas of autoimmune diseases and idiopathic male infertility. Its pipeline includes AZD1656, which has completed Phase I trials for the treatment of type 2 diabetes, renal transplant, Hashimoto's thyroiditis, uveitis, and preterm labor; and AZD5904, which…
Price chart
Seasonality
May has 1 positive and 3 negative years (last 5 years shown)
-57% return in May, -20% avg return in past 3 year May month.
-233% return in 2026, -232% avg return in past 3 years.
Swipe sideways to see all months →
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Yr | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | -16% | -37% | -69% | -54% | -57% | – | – | – | – | – | – | – | -233% |
| 25 | -64% | -49% | -33% | -33% | -60% | -29% | -33% | -27% | -49% | -45% | -27% | -30% | -479% |
| 24 | -42% | -1% | 27% | -21% | 0% | -64% | -77% | -47% | -14% | -25% | 20% | -36% | -279% |
| 23 | 1% | 0% | 2% | 1% | 1% | 0% | 1% | -1% | -44% | -70% | 171% | 0% | 61% |
| 22 | – | – | 0% | 0% | 0% | 1% | 0% | 0% | 0% | 1% | 1% | 1% | 3% |
Monthly return % by calendar month · historical pattern, not a forecast
Bearish · Downtrend · Oversold
CDT Equity Inc., a clinical-stage specialty biopharmaceutical company, develops pharmaceutical products that provides unmet medical needs in the areas of autoimmune diseases and idiopathic male infertility. Its pipeline includes AZD1656, which has completed Phase I trials for the treatment of type 2 diabetes, renal transplant, Hashimoto's thyroiditis, uveitis, and preterm labor; and AZD5904, which has completed Phase I clinical trials for the treatment of idiopathic male infertility. It has strategic services agreement with formulation development CDMO Agility Life Sciences to develop new solid oral-dosage form products. The company was formerly known as Conduit Pharmaceuticals Inc. and changed its name to CDT Equity Inc. in August 2025. The company was founded in 2019 and is based in Naples, Florida.
Full AI Q&A, portfolio tracking, and live alerts in the app.
Key metrics
Market cap
$9.23M
P/E ratio
—
52W high
$878.0
52W low
$0.79
Volume
2,88,588
Beta
1.57
Related stocks in Healthcare
Merck & Co Inc Cedear (5…
₹32,900
Abbott Laboratories Cede…
₹30,500
Eli Lilly And Company Ce…
₹25,540
Unitedhealth Group Inc C…
₹17,200
₹6,600
Frequently asked questions
- What is CDT Equity Inc. share price today?
- CDT Equity Inc. (CDT) last traded around $0.88 on StockPro. Prices refresh every few minutes during market hours.
- What technical signals does CDT have?
- StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for CDT. Download the app for real-time alerts.
- How can I analyze CDT Equity Inc. stock?
- Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.